Research
Metabolic adaptation
Metabolic dysfunction-associated steatotic liver disease (MASLD) is very common in individuals with type 2 diabetes.
Healthcare providers should be aware of the high prevalence of MASLD in their diabetic patients.
StrongSupportsmedium confidence
Metabolic dysfunction-associated steatotic liver disease (MASLD) is very common in type 2 diabetes individuals.
Why this rating
The claim is based on a review of existing literature.
Source
Treatment Modalities for Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Review Article
V. Damle et al. · Journal of Diabetology · 2026
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →